🇺🇸 FDA

Drug profile · INN

carmustine

CARMUSTINE MEDAC (PREVIOUSLY CARMUSTINE OBVIUS)

approved L01AD01
US status
approved
Patents linked
0
News articles
0

Quick answer

carmustine (CARMUSTINE MEDAC (PREVIOUSLY CARMUSTINE OBVIUS)) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: intracranial. Current US regulatory status: approved.

Key facts

INN carmustine
Brand CARMUSTINE MEDAC (PREVIOUSLY CARMUSTINE OBVIUS)
Route INTRACRANIAL
Formulation INJECTABLE
ATC code L01AD01
Originator Amneal Pharma Europe Ltd

Frequently asked questions

What is carmustine?

carmustine (CARMUSTINE MEDAC (PREVIOUSLY CARMUSTINE OBVIUS)) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: intracranial. Current US regulatory status: approved.

What is the brand name for carmustine?

CARMUSTINE MEDAC (PREVIOUSLY CARMUSTINE OBVIUS) is a marketed brand name for carmustine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of carmustine?

carmustine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.